Table 2 Baseline characteristics of type 1 and type 2 diabetes patients
| Â | Type 1 DM | Type 2 DM |
|---|---|---|
Age | (%) | (%) |
 15–19 | 5.4 | 0.2 |
 20–24 | 15.0 | 1.1 |
 25–29 | 16.7 | 1.7 |
 30–34 | 18.0 | 3.1 |
 35–39 | 10.0 | 4.6 |
 40–44 | 9.6 | 8.5 |
 45–49 | 8.7 | 15.3 |
 50–54 | 10.4 | 16.2 |
 55–59 | 2.5 | 17.2 |
 60–64 | 3.0 | 18.8 |
 65–69 | 0.8 | 13.1 |
 70–74 | 0 | 0.2 |
Sex | Â | Â |
 Male | 62.5 | 67.0 |
 Female | 37.5 | 33.0 |
Marital status | ||
 Single | 55.0 | 21.8 |
 Co-habiting/married | 40.8 | 61.6 |
 Separated/divorced | 3.7 | 12.4 |
 Widowed | 0.4 | 4.1 |
Higher education | ||
 Up to class 8 | 9.6 | 27.1 |
 Junior high school | 20.0 | 22.5 |
 Up to class 10 | 0.0 | 5.0 |
 Advanced technical college | 13.3 | 12.2 |
 Secondary school examination | 55.0 | 30.6 |
 No education | 0.4 | 0.7 |
 Other types of education | 1.2 | 1.7 |
 No response* | 0.4 | 0.2 |
Employment | ||
 Laborer | 9.2 | 16.2 |
 Employee | 54.6 | 61.3 |
 Official | 5.4 | 5.0 |
 Business man | 7.2 | 10.0 |
 Farmer | 0 | 0.2 |
 Self-employed worker | 2.1 | 3.5 |
 Non-employed | 0.8 | 0 |
 Other professions | 5.4 | 1.5 |
 No response/advanced educationa | 1.2 | 0.2 |
Medical insurance | ||
 Private | 15.8 | 12.4 |
 Government/public | 77.9 | 81.9 |
 Other insurance | 5.8 | 4.6 |
 No insurance | 0 | 0 |
 No response | 0.5 | 1.1 |
Regular medical checks | ||
 Yes | 35.8 | 56.1 |
 No | 63.7 | 42.8 |
 No responsea | 0.4 | 0.9 |
Family history of diabetes | ||
 Mother | 16.1 | 32.7 |
 Father | 17.3 | 26.3 |
 Children | 0.8 | 1.7 |
 Brothers and sisters | 7.6 | 18.4 |
 Grandparents | 37.3 | 35.2 |
 Uncles and aunts | 15.8 | 20.0 |
Other diseases/risk factors/comorbidities | ||
 Hypertension | 18.5 | 63.3 |
 History of myocardial infarction | 0.4 | 2.8 |
 Retinopathy | 0.8 | 1.3 |
 History of or current smoking | 73.3 | 88.9 |
 Subclinical DSPN | 9.8 | 6.9 |
 Confirmed asymptomatic DSPN | 0.4 | 2.6 |
 Confirmed symptomatic DSPN | 2.2 | 4.0 |
 Possible DSPN | 7.2 | 23.2 |
 Probable DSPN | 0.5 | 5.3 |
 Subclinical/borderline CAN | 0.9 | 2.1 |
 Definite CAN | 1.4 | 2.4 |
Medication | ||
Glucose lowering therapy | ||
 Insulin, short acting | 87.9 | 5.9 |
 Insulin, long acting | 54.2 | 4.8 |
 Metformin | 14.6 | 56.1 |
 Sulfonylurea | 1.3 | 3.5 |
 Dipeptidyl-peptidase-4 inhibitors | 1.3 | 6.6 |
 GLP-1-Agonists | 0.4 | 2.0 |
Other therapies | ||
 Acetylsalicylic acid | 1.7 | 11.1 |
 Statins | 2.5 | 17.5 |
 Fibrates | 0.0 | 0.7 |
Any antihypertensive therapy | ||
 Blockers of the renin-angiotensin system | 2.1 | 15.9 |
 Beta blockers | 2.9 | 25.3 |
 Calcium channel blockers | 0.8 | 13.8 |
 Diuretics | 0.4 | 8.3 |